| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.02 |